Related Experiment Video
Updated: May 22, 2026
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
RNA Modifications as Drug Targets: Unlocking the Therapeutic Potential of the Epitranscriptome
Dhananjay Taumar1, Atul Pratap Singh2, Himanchal Sharma2
1Department of Pharmacy, IIMT College of Medical Sciences, IIMT University, Meerut, India.
Current Genomics
|May 21, 2026
Summary
The epitranscriptome, or reversible RNA changes, influences gene expression and disease. Targeting these RNA modifications offers promising therapeutic strategies for various conditions, though challenges remain.
Area of Science:
- Molecular Biology
- Epigenetics
- RNA Biology
Background:
- The epitranscriptome involves reversible modifications to RNA, impacting gene expression, stability, and degradation.
- These RNA alterations are increasingly linked to disease pathogenesis, presenting novel therapeutic targets.
- Understanding epitranscriptomic regulation is crucial for developing innovative treatment strategies.
Purpose of the Study:
- To review the landscape of RNA modifications within the epitranscriptome.
- To explore the biological functions and regulatory mechanisms of these modifications.
- To evaluate the clinical applications and therapeutic potential of targeting epitranscriptomic changes.
Main Methods:
- Systematic literature analysis of experimental, clinical, and computational research.
- Classification of RNA modifications based on biochemical properties and biological functions.
- Evaluation of current therapeutic approaches, including small molecules, CRISPR/Cas, and RNA-targeted strategies.
Main Results:
- Key RNA modifications include N6-methyladenosine (m6A), 5-methylcytosine (m5C), and pseudouridine.
- Gene regulation involves a network of 'writers,' 'erasers,' and 'readers' that control RNA modifications.
- Targeted epitranscriptomic therapies show potential for treating cancer, neurodegenerative, and viral diseases.
Conclusions:
- The epitranscriptome represents a significant regulatory layer with substantial therapeutic promise.
- Emerging techniques for modulating RNA modifications are advancing rapidly.
- Overcoming limitations such as delivery vehicles and side effects is essential for clinical success.
Related Concept Videos
01:36What is Gene Expression?
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then processed and...
01:42What is Gene Expression?
Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
02:23RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
01:53RNA Stability
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...